Morgan Stanley raises CSX price target to $32
Morgan Stanley analyst Ravi Shanker maintains an Underweight rating on CSX but raises the price target to $32 from $30, reflecting a revised valuation outlook.

*this image is generated using AI for illustrative purposes only.
Morgan Stanley analyst Ravi Shanker has maintained an Underweight rating on CSX (NASDAQ: CSX) while raising the price target to $32 from $30. The revised target indicates a shift in valuation expectations despite the continued cautious stance.
Rating and Price Target Details
The Underweight rating suggests that the stock is expected to underperform relative to the broader market or sector benchmarks. The price target increase to $32 implies a specific upside potential based on the firm's analysis.
| Metric | Value |
|---|---|
| Rating | Underweight |
| Previous Price Target | $30 |
| New Price Target | $32 |
Analyst Perspective
Ravi Shanker's recommendation highlights a nuanced view, balancing a higher price target with a conservative rating. This dual adjustment signals updated financial modeling or market conditions affecting CSX's projected performance.
What specific factors drove the price target increase despite the maintained Underweight rating?
How might CSX's upcoming earnings report influence Morgan Stanley's future stance on the stock?
What market conditions or sector trends could lead to a potential rating upgrade for CSX?


























